Coloplast A/S Stock

Equities

COLO B

DK0060448595

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Copenhagen 10:59:39 2024-05-31 am EDT 5-day change 1st Jan Change
824.8 DKK -0.31% Intraday chart for Coloplast A/S -2.30% +6.84%
Sales 2024 * 27.04B 3.93B Sales 2025 * 29.38B 4.27B Capitalization 185B 26.97B
Net income 2024 * 5.25B 764M Net income 2025 * 6.12B 891M EV / Sales 2024 * 7.58 x
Net Debt 2024 * 19.4B 2.82B Net Debt 2025 * 18.06B 2.63B EV / Sales 2025 * 6.93 x
P/E ratio 2024 *
35.5 x
P/E ratio 2025 *
30.3 x
Employees 15,930
Yield 2024 *
2.44%
Yield 2025 *
2.67%
Free-Float 58.44%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.31%
1 week-2.30%
1 month-2.55%
3 months-9.92%
6 months+2.08%
Current year+6.84%
More quotes
1 week
802.20
Extreme 802.2
859.20
1 month
802.20
Extreme 802.2
881.00
Current year
757.80
Extreme 757.8
977.60
1 year
689.20
Extreme 689.2
977.60
3 years
689.20
Extreme 689.2
1 194.00
5 years
689.20
Extreme 689.2
1 194.00
10 years
413.10
Extreme 413.1
1 194.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 07-12-31
Director of Finance/CFO 52 05-12-31
Chairman 65 87-12-31
Members of the board TitleAgeSince
Director/Board Member 76 68-09-30
Director/Board Member 60 17-11-30
Chairman 65 87-12-31
More insiders
Date Price Change Volume
24-05-31 824.8 -0.31% 1,276,697
24-05-30 827.4 +0.66% 293,451
24-05-29 822 -2.42% 296,060
24-05-28 842.4 -1.96% 184,191
24-05-27 859.2 +1.78% 70,720

Delayed Quote Nasdaq Copenhagen, May 31, 2024 at 10:59 am EDT

More quotes
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.; - ostomy care products (36.8%): bags and equipment used following intestinal operations; - wound care and skincare products (11.9%): wound dressings, bandages, creams and gels; - voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
824.8 DKK
Average target price
909.9 DKK
Spread / Average Target
+10.32%
Consensus
  1. Stock Market
  2. Equities
  3. COLO B Stock